Mucopolysaccharides Medical Genetics Dr Derakhshandeh, PhD.

Slides:



Advertisements
Similar presentations
Birth Defects.
Advertisements

Genetic Diseases.
Israel Alfonso, MD INSTRUCTIONS READ EACH QUESTION
Human Genetic Disorders
TURNER sYNDROME By: Jazmin Barnes.
Syndromes and Birth Defects
Chapter 12: Patterns of Heredity & Human Genetics
Human Heredity and Genetic Disorders
Fragile x syndrome By Jordon Nagel.
Genetic Disorders.
GENETIC DISORDERS.
 FOLLOWING PATTERNS OF INHERITANCE. Humans cannot undergo breeding experiments for use in genetic studies – ethical implications.
- When DNA Mutates. MUTATION A heritable change in the nucleotide sequence of an organism’s DNA.
Effects of Alcohol During Pregnancy. How does consuming alcohol effect your baby’s development? Your baby is continually growing throughout the nine months.
Interesting Genetic Disorders and Diseases, and Abnormalities.
Genetic Disorders and Birth Defects. Cleft lip/pallet Affects: anyone, more common in asians and native americans When appears: birth Method of inheritance:
27.3 Genetic Disorders Errors in the chromosome number
Hemoglobin. Sickle cell anemia is a genetic blood disorder, caused by a single mutation in the gene for hemoglobin. It is found primarily in people of.
Ch 20 Lesson 2 From Generation to Generation. Things to do before we start class…  Take out Prenatal Development Worksheet.
What is polygenic and what traits are polygenic? Agenda for Monday Feb 9 th 1.Disorders.
Sally Freese Family and Consumer Science
Ashley Osborne Quesha McClanahan Orchi Haghighi
Fetal Alcohol Syndrome:
Ataxia Telangiectasia By: Leon Richardson Period
Osteogenesis imperfecta
Problems in Prenatal Development
11.1 GENETIC DISORDERS  BACKGROUND INFORMATION (Early 1900s) Sir Archibald Garrod, British physician, discovered patterns of inheritance leading to alkaptonuria—
Inborn Errors of Metabolism Monica Egan. Video Links Part 1: – xWwY&feature=plcphttp://
Phenylketonuria (PKU) By: Greg Ancmon and Brennan Ramos Period 2.
7-5 Phenylketonuria Report
Basic Patterns of Human Inheritance Section 11.1 Page 296.
PKU- Cell Storage Disorder!! By: Brianna Hopkins.
Presenters: PICU/AO1 UNIT Moderators: Dr Somwe Dr Mwenechanya
1 Principles of Diagnosis of Genetic Diseases using Molecular and Cytogenetic Dr Pupak Derakhshandeh, PhD Ass Prof Medical Science of Tehran University.
HEREDITARY METABOLIC DISEASES. Particular risk factors are: Advanced maternal age (e.g. Down's syndrome) Family history of inherited diseases (e.g. fragile.
By: AHMAD SALLEHUDDIN BIN MUKHTARUDDIN D11A001 & ALVIN LEE JIN WEN D11A003.
November 11, Undernutrition 61/2 m/o ex 34 WGA twins with: FTT Severe Global Developmental Delay Hypertonia Oculomotor findings Reflux.
Genetic Disorders What is a Genetic Disorder? Caused by abnormalities in an individual’s genetic material (the DNA, or the genome). There are four different.
Glycogen Storage Diseases:
Diseases and karyotypes
4.3 Alterations In Chromosome Structure and Number
Heredity and Genetics (2:39) Click here to launch video Click here to download print activity.
DAY 2 Unit 3 Inheritance and Molecular Genetics 1.
Human Genetic Disorders Every cell in the human body has 46 chromosomes except for gametes, egg sperm cells, which contain 23 or the haploid number. Human.
Cri-du-chat Syndrome By: Maddy Gordon. What is Cri-du-chat syndrome? Cri-du-chat syndrome is a rare chromosomal condition that results when a piece of.
Lysosomal Storage Diseases. Fabry’s Disease What kind? Symptoms? Enzyme Def? What accumulates? Inheritance Pattern? Sphingolipidosis Peripheral neuropathy,
An Ounce of Prevention  2000, 2005, 2011 The Curators of the University of Missouri Chapter 3 Alcohol.
Canavan’s Disease By Carissa D’Agostino.
Presented By: Stephanie Asselstine & Jessica Williams.
1.Is NS-NPD caused by defect in a single gene or is more than one gene involved? Mutations in the NPC1, NPC2, and SMPD1 genes cause Niemann-Pick disease.
Sex - Linked Genes and Nondisjunction Disorders. Human Chromosomes One Human Chromosome has 46 chromosomes.
Mackenzie Walsh.  Dr. Harry Angelman noticed a condition in 3 children  He was a British pediatrician  Early 1980s- more cases were reported.
A defect of the 21 st chromosome By: Nur Ajeerah Esah Binti Zainuddin Dietetic 3.
Pedigrees 4/13/2010 Pedigrees The risks of passing on a genetic disorder to offspring can be assessed by genetic counseling, prenatal testing, and by.
GENETIC BASIS OF DISEASE- part 2. Genetic basis of disease part 2 objectives a. Define inborn errors of metabolism b. Describe the common characteristic.
Presentation On gaucher’s disease
Nanette Safonts Period 3
Severe MPS II (Hunter syndrome) in a 6-year-old boy
A family history of a genetic condition or trait
A family history of a genetic condition or trait
Down Syndrome Vanessa Tam 12A.
HEREDITARY METABOLIC DISEASES
Inherited Human Disorders
Ch. 4.3 Notes Problems in Prenatal Development
MUCOPOLYSACCHARIDOSIS-MPS
Presentation transcript:

Mucopolysaccharides Medical Genetics Dr Derakhshandeh, PhD

2 Definition  A gel-like substance found in:  body cells  mucous secretions  synovial fluids

3Mucopolysaccharidoses  Genetic disorders  Deficiency of enzymes necessary to breakdown mucopolysaccharides (MPS)  Excessive accumulation of mucopolysaccharides in body tissues

4 Mucopolysaccharidoses Results: –many serious physical disorders –Various genetic deformities such as: skeletal deformities (especially of the face) mental retardation decreased life expectancy

5 Examples Hunter syndrome Hurler syndrome Scheie syndrome Sanfilippo syndrome Morquio disease Maroteaux-Lamy syndrome

6

7 Hurler syndrome type I ( Alpha-L-iduronate deficiency )

8 Hurler syndrome type I Definition An inherited disease (AR) Storage of abnormal quantities of this material (mucopolysaccharide) in different body tissues is responsible for the symptoms and appearance of the disease

9 Hurler syndrome (type I)

10 Hurler syndrome type I

11 Key Symptom Images Claw hand Coarse facial features Corneal clouding Hernia Mucopolysaccharidosis I (MPS I) Disease (Hurler, Hurler-Scheie, Scheie Syndromes)

12 Causes of the Hurler syndrome Inherited as an autosomal recessive trait Metabolic defect: inability –The body's to make an enzyme: lysosomal alpha-L-iduronase lysosomal alpha-L-iduronase

13 incidence & and risk factors Approximately 1 in 150,000 infants are affected Newborn infants with this defect appear normal at birth By the end of the first year, signs of impending problems begin to develop

14 MPS (Type I) The children slowly develop Coarse, thick, facial features Prominent dark eyebrows Progressive stiffness Mental retardation

15Prevention Genetic counseling: important for parents with a family history of Hurler syndrome Prenatal diagnosis: An amniocentesis in the amniotic fluid are then cultured and the a-L-iduronidase activity in the cells is determined.

16Symptoms Short stature Severe mental retardation Thick, coarse facial features with low nasal bridge Full lips with a thick, large tongue Increased body hair (hirsutism)

17 Symptoms Umbilical hernia Deafness Stiffness (in joints) Shortness of breath Abnormal bones of spine and claw hand

18 MPS: Signs HepatomegalySplenomegaly Enlarged tongue Retinal pigmentation Hip dislocation Kyphosis Heart murmurs Heart valve damage from thickening

19 Tests that may indicate the syndrome Increased excretion of dermatan sulfate and heparan sulfate in the urine Absence of lysosomal alpha-L- iduronidase (in cultured fibroblasts) Culture of cells from amniotic fluid obtained by amniocentesis for enzyme testing (prenatal testing)

20 Tests that may indicate the syndrome Abnormal histological staining of white blood cells called metachromasia X-ray of the skeleten X-ray of the spine X-ray of the chest ECG

21 Hunter syndrome type II (Sulpho-idoronide sulphatase deficiency )

22 Hunter syndrome type II

23 Hunter syndrome type II

24 Hunter syndrome type II (Sulpho-idoronide sulphatase deficiency ) X-linked Coarse, thick, facial features Progressive stiffness decreased mental development Hepatomegaly (liver enlargement) Splenomegaly (spleen enlargement) Abnormal bone x-rays

25 Sanfilippo syndrome type III

26 Sanfilippo syndrome type III

27 Sanfilippo syndrome type III

28 Sanfilippo syndrome type III Definition Sanfilippo syndrome is one of the hereditary mucopolysaccharide storage diseases it is characterized by the absence of one of several enzymes These enzymes help the body get rid of a substance normally found outside of our cells called a mucopolysaccharide This substance is called heparan sulfate, and in Sanfilippo syndrome, large amounts of it are excreted in the urine

29 Alternative Names Mucopolysaccharidosis type III subtypes A - B – C - D Type IIIA: heparan sulfate sulfatase deficiency Type IIIB: N- acety-glucos-aminidase- deficiency Type IIID: N-acetyl-glucos- amine-6-sulfate sulfatase deficiency

30 Sanfilippo syndrome Causes an autosomal recessive trait It is possibly the most common of the mucopolysaccharide storage diseases It has a relatively late onset rather than during the first year of life It has a relatively late onset rather than during the first year of life

31Causes Coarse, thick, facial features Prominent dark eyebrows Progressive stiffness gait disturbances speech disturbances decreased mental development that progresses to severe mental retardation

32Prevention Genetic counseling: important for prospective parents with a family history of Sanfilippo syndrome Prenatal diagnosis: An amniocentesis in the amniotic fluid are then cultured and the enzyme activity in the cells is determined.

33 Symptoms Family history of Sanfilippo syndrome May have normal growth during first few years, but final height is below average Delayed development followed by deteriorating mental status Deterioration of gait Coarse facial features Full lips Heavy eyebrows that meet in the middle of the face above the nose Diarrhea Stiff joints that may not extend fully

34 Sanfilippo syndrome Signs and tests Hepatomegaly (liver enlargement) Splenomegaly (spleen enlargement) Corneas clear Echocardiogram may show thickened heart Abnormal bone x-rays such as thickened skull and oval vertebrae

35 Sanfilippo syndrome Signs and tests Seizures mental retardation Activities of one of the enzymes may be low in fibroblast skin cells Urine may have increased heparan sulfate Abnormal pathological staining character of white blood cells called metachromasia

36 Features and Characteristics children with Sanfilippo syndrome Occasional enlarged head Coarse facial features Coarse hair Excessive hair growth Joint stiffness

37 Sanfilippo syndrome Severe diarrhea or constipation Severe hearing loss Hyperactivity Aggressive and destructive behavior Poor attention Physical aggression Speech and language delay Sleep disturbance Severe intellectual impairment most often before 6 years of age Mild growth retardation Vision impairment

38 Morquio syndrome Type IV

39 Morquio syndrome Type IV Skeletal abnormality - hand

40 Skeletal abnormality: flattened vertebrae

41

42 Morquio syndrome Type IV subtypes A & B Type IVA: Galactose-6- sulfatase deficiency Type IVB:  Galactosidase deficiency

43 Features and Characteristics children with Morquio syndrome Joint stiffness Mild growth retardation Stiff joints that may not extend fully Without mental retardation ! Abnormal bone x-rays –X-ray of the skeleten –X-ray of the spine –X-ray of the chest

44 Prevention Genetic counseling: important for prospective parents with a family history of Morquio syndrome Prenatal diagnosis: An amniocentesis in the amniotic fluid are then cultured and the enzyme activity in the cells is determined.

45 Maroteaux-Lamy syndrome Type V (N-Acetyl-galactose-amin-4- sulfatase (Arylsulfatase B)

46 Maroteaux-Lamy syndrome TypeV

47 Maroteaux-Lamy syndrome TypeV

48 Features and Characteristics Maroteaux-Lamy syndrome Coarse facial features

49Treatment At the present time, there is no cure for MPS disorders. Enzyme replacement therapy and gene therapy are the two treatments that researchers have been focusing on to eventually cure MPS diseases. There are a number of research institutions around the world working on finding a cure for the MPS diseases including facilities in the United States, Canada, England, and Australia.